Related Experiment Video
Updated: Sep 21, 2025
12:58
Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line
Published on: May 10, 2017
9.5K
Moving Beyond Patient-Level Drivers of Racial/Ethnic Disparities in Childhood Cancer
Xu Ji1,2, Heeju Sohn3, Soumitri Sil1,2
1Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia.
Summary
Racial and ethnic disparities persist in childhood cancer survival, with lower rates for Black and Hispanic children. Addressing multi-level barriers is crucial for achieving equitable health outcomes in pediatric cancer care.
Area of Science:
- Pediatric Oncology
- Health Disparities Research
- Social Determinants of Health
Background:
- Persistent racial/ethnic disparities in childhood cancer survival rates are evident, with non-Hispanic Black and Hispanic children experiencing lower survival compared to non-Hispanic White children.
- These disparities exist across various hematologic cancers and solid tumors, indicating a systemic issue rather than disease-specific factors.
Discussion:
- A complex systems and social determinants of health framework is proposed to understand the drivers of these disparities.
- Pediatric cancer patient experiences are mediated by caregivers, family structures, and societal contexts, influencing healthcare interactions.
- Dismantling multi-level barriers—patient, family, healthcare system, and structural—is essential for developing targeted interventions.
Key Insights:
- Racial/ethnic disparities in pediatric cancer survival are a significant public health concern.
- Social determinants of health and systemic factors play a critical role in these survival gaps.
- A multi-level approach is necessary to address and mitigate these inequities.
Outlook:
- Further research is needed to examine family, healthcare system, and societal factors contributing to disparities.
- Development and implementation of policies and interventions are critical to promote equitable childhood cancer outcomes.
- Focusing on modifiable drivers at all levels can lead to substantial improvements in health equity for pediatric cancer patients.
Related Concept Videos
02:59Cancer Prevention
6.3K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.3K
01:18Factors Affecting Illness
4.5K
When a person's physical, emotional, intellectual, social development or spiritual functioning is compromised, this deviation from a healthy normal state is called illness. Illness creates stress that in turn harms individuals. Irritation, anger, denial, hopelessness, and fear are behavioral and emotional changes an individual experiences in the phases of illness. A variety of factors influence a person's health and well-being.
For instance, risk factors are connected to illness,...
For instance, risk factors are connected to illness,...
4.5K
01:29Factors Affecting Protein-Drug Binding: Patient-Related Factors
123
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
123
01:19Factors Affecting Drug Distribution: Miscellaneous Factors
556
Drug distribution in the human body is a complex process influenced by various individual factors, including age, pregnancy, obesity, diet, body water composition, pH levels, and specific disease conditions.
Age plays a significant role due to differences in body composition among different age groups. Infants, for instance, have a higher proportion of total body water and lower albumin levels, a protein that binds drugs in the bloodstream. This unique composition in infants enhances the...
Age plays a significant role due to differences in body composition among different age groups. Infants, for instance, have a higher proportion of total body water and lower albumin levels, a protein that binds drugs in the bloodstream. This unique composition in infants enhances the...
556
01:21Cancer Survival Analysis
463
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
463
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K